NFG
KDNY

Next Financial Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Next Financial Group’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-40
Closed -$5K – 1896
2015
Q4 		$5K Buy
40
+20
+100% +$2.72K ﹤0.01% 1406
2015
Q3 		$1K Hold
20
– – ﹤0.01% 1771
2015
Q2 		$3K Buy
+20
New +$3.3K ﹤0.01% 1625

Other funds holding KDNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Next Financial Group's KDNY Position: Q1 2016 in Review

Next Financial Group sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q1 2016, closing a stake of 40 shares — an estimated $5K sold.

Next Financial Group first reported a position in KDNY in Q2 2015 and held it in 3 quarters. The position peaked at $5K in Q4 2015. 89 funds tracked by Wall St. Rank hold KDNY as of Q1 2016.

  • Next Financial Group reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Next Financial Group sold 40 Chinook Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $5K.
  • Next Financial Group first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 3 quarters.
  • Next Financial Group's Chinook Therapeutics, Inc. Common Stock position peaked at $5K in Q4 2015.
  • 89 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q1 2016.

Based on Next Financial Group's 13F filing for Q1 2016, filed 20 Apr 2016.